Search Results 351-360 of 8936 for Conduction

1. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   Conduction abnormality requiring a pacemaker; Symptomatic pericarditis; Myocardial infraction within the last 6 months, documented by persistent elevated ...

2. A Phase 2/3 Study of GLASSIA for the Treatment of Acute GvHD - Mayo Clinic

   ... conduction system abnormalities. Prior to the first dose of study treatment, any electrocardiogram (ECG) abnormality at screening must be documented by the ...

3. UT Split Tear Overview-Wrist pain - Youtube

   There is a nerve that goes right through that area but again this was not nerve pain. And then there was the the socket, the ligament tissue that forms the ...

4. A Study Evaluating MM-310 in Patients With Solid Tumors - Mayo Clinic

   ... conduction abnormalities, or controlled and well treated chronic atrial fibrillation); Patients who are not appropriate candidates for participation in this ...

5. Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Severe uncontrolled ventricular arrhythmias or electrocardiographic evidence of active conduction system abnormalities; Cardiac amyloidosis with hypotension ...

6. A Study Using Docetaxel with or without MLN1117 in Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer - Mayo Clinic

   ... conduction system abnormalities; Fridericia's corrected QT interval > 475 milliseconds (msec) (males) or > 450 msec (females) on a 12-lead ECG during the ...

7. Tachycardia - Symptoms and causes - Mayo Clinic

   https://www.merckmanuals.com/professional/cardiovascular-disorders/arrhythmias-and-conduction-disorders/overview-of-arrhythmias. Accessed Nov. 22, 2023 ...

8. A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma - Mayo Clinic

   History or presence of clinically significant ventricular arrhythmias, atrial fibrillation, resting bradycardia, or conduction abnormality;; Unstable angina ...

9. A Study of Taxane, Trastuzumab, and Pertuzumab With or Without Atezolizumab in Treating Metastatic Breast Cancer Patients - Mayo Clinic

   Conduction abnormality requiring a pacemaker;; Valvular disease with documented compromise in cardiac function; or; Symptomatic pericarditis. History of ...

10. 221AD302 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease - Mayo Clinic

    History of unstable angina, myocardial infarction, advanced chronic heart failure, or clinically significant conduction abnormalities within 1 year prior to ...